13 Cheap Healthcare Stocks with Huge Upside Potential
On July 8, Kate Moore, Citi Wealth CIO, appeared on CNBC's 'Squawk Box' to talk about the recent rally in equities.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 3,241,361 | $1,409,862,551 | +1% | 2.94% |
| 2. | Orbis Investment Management William B. Gray | 2,849,173 | $1,239,276,288 | +32% | 7.09% |
| 3. | Harris Associates Natixis Global Asset Management | 2,280,159 | $991,777,969 | +26% | 1.67% |
| 4. | Eagle Capital Management Boykin Curry | 1,585,348 | $689,562,966 | +2% | 2.52% |
| 5. | Brave Warrior Capital Glenn Greenberg | 1,577,570 | $686,179,847 | -4% | 15.72% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing | |
| $296.03 | 1,700 | $503,251.00 | 2,921 | 2021-02-04 | Filing | |
| $264.22 | 2,000 | $528,440.00 | 26,556 | 2020-01-30 | Filing | |
| $263.52 | 5,600 | $1,475,712.00 | 24,556 | 2020-01-30 | Filing | |
| $57.30 | 144 | $8,251.20 | 61,025 | 2010-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,344 | $3,634,442 | 0.09% | |
| 2. | 7,840 | $3,049,484 | 0.65% | |
| 3. | 7,024 | $2,732,055 | 0.74% | |
| 4. | 6,500 | $2,528,240 | 2.37% | |
| 5. | 4,410 | $1,715,412 | 0.15% |
News See All
Wells Fargo Maintained a Buy Rating on Elevance Health (ELV), Kept the PT Unchanged
Elevance Health, Inc. (NYSE:ELV) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 18, Wells Fargo analyst Stephen Baxter maintained a Buy rating on Elevance Health, Inc.
11 Best 52-Week Low Stocks to Buy Right Now
On July 2, Tom Lee, Fundstrat's Head of Research and CIO, joined CNBC Television to discuss market conditions. He noted that the investors remain skeptical despite strong market gains.
UBS Reaffirms Buy on Elevance Despite Adjusted 2025 Earnings Outlook
Elevance Health, Inc. (NYSE:ELV) ranks among the best fundamental stocks to buy according to hedge funds. On June 17, UBS reaffirmed its Buy rating and $555 price target for Elevance Health, Inc.
Elevance Health (ELV) Gets Overweight Rating from Cantor Despite Margin Headwinds
Elevance Health, Inc. (NYSE:ELV) is one of billionaire Leon Cooperman’s top stock picks with huge upside potential.
Billionaire Leon Cooperman's 8 Stock Picks with Huge Upside Potential
The chairman and CEO of Omega Advisors, Leon Cooperman, is a highly esteemed figure renowned for his generosity, market and economic analysis, and shrewdness.
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating
Elevance Health Inc. (NYSE:ELV) is one of the 8 Best Inexpensive Stocks to Buy Right Now.
8 Best Inexpensive Stocks to Buy Right Now
On June 7, Torsten Slok, Apollo Global Management, joined 'Closing Bell Overtime' on CNBC to discuss the US jobs report and the broader economic landscape.
Elevance Health (ELV) Reported Strong Q1 Results
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” first quarter 2025 investor letter.
Billionaire Hedge Funds
